Robert Pignolo

25PUBLICATIONS
72CO-AUTHORS
Molecular targetsRadiation therapyDisease surveillanceAdolescent healthCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 15, 2026
BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva.

|Aug 08, 2026
Suppression of early pro-inflammatory senescent signature post-radiotherapy mitigates chronic bone damage.

|Jul 22, 2026
Incidence of RSV-Acute Respiratory Infection in Adults 18-64 Years With High-Risk Conditions: A Prospective Community-based Surveillance Study.

|Mar 23, 2026
Suppression of early pro-inflammatory senescent signature post-radiotherapy mitigates chronic bone damage.

David Achudhan, Jacob Orme, Ritika Sharma

|Feb 05, 2026
Scoliosis in Fibrodysplasia Ossificans Progressiva: A Report of 4 Cases.

Zaid Elsabbagh, Myung-Jin Cha, Robert J Pignolo

|Oct 27, 2025
Medical guidelines for fibrodysplasia ossificans progressiva.

Frederick S Kaplan, Mona Al Mukaddam, Genevieve Baujat

Pageof 5

Frequent Collaborators

8 joint publications

Sundeep Khosla

7 joint publications

Abhishek Chandra

5 joint publications

David G Monroe

4 joint publications

Joshua N Farr